While the number of Biobanks worldwide is growing rapidly, quality control of the whole process Is a requirement to ensure the value of the biobanks. Standardization is needed to allow researchers to integrate results obtained of specimen tests from 1 or more biobanks. Standardization also includes the QC Process, which needs to cover all aspects of pre-analytics and sample storage. In addition validation of specimen/donor metaparameters is of additional value.
NMR is especially suited to perform QC-analysis of liquid biopsies and can deliver a large number of criteria based on one QC measurement per sample. In addition to QC Information NMR can deliver a large number of metabolic information using the same spectra generated during the QC process. With this information in urine 150 metabolites in 2 age ranges are quantified. In plasma/serum 115 lipoprotein related parameters (including subclasses) and 26 metabolites/parameters are analyzed and quantified, the whole process is under push button automation and can be handled by a trained medical technical assistant.
除了质量控制、生物银行现在可以upport epidemiological studies or clinical trials by using the metadata of selected NMR spectra or quantification results. This will reduce the need for new aliquots and substantially reducing the cost of clinical trials or research studies. Further savings can be gained by sharing the spectral data. New NMR-based diagnostic tests can be validated on a worldwide basis and on multiple phenotypes without exploding the cost of the trial. Data generated from an 11 IVDr platform Inter-Laboratory Trial proves this unique benefit of NMR1.
Bruker’s commitment to provide customers with unparalleled help throughout the buying cycle, from initial inquiry to evaluation, installation, and the lifetime of the instrument is now characterized by the LabScape service concept.
LabScape Maintenance Agreements, On-Site On-Demand and Enhance Your Lab are designed to offer a new approach to maintenance and service for the modern laboratory